New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2014
08:47 EDTBF.B, HCN, SHLD, MCK, MYL, PFE, LMCA, BF.A, VTR, FOXA, MHFI, ACT, TWC, BEAM, DTV, TGT, CAKFY, NDAQ, VRX, CHTROn the Fly: Periodicals Wrap
WSJ: DirecTV (DTV) wants Weather Channel fee reduction as apps take hold...Brown-Forman (BF.A, BF.B) may benefit from Beam (BEAM) deal...REUTERS: Malone (LMCA, CHTR) seeks consolidation in Time Warner Cable (TWC) bid...Pfizer's (PFE) generics unit attracts several suitors (VRX, ACT, MYL)...Nasdaq (NDAQ), S&P (MHFI) interested in acquisitions to grow index businesses...BLOOMBERG: McKesson (MCK) considers JV following failure of Celesio (CAKFY) bid...Fox (FOXA) won't participate in network TVís pilot season...Sears (SHLD) may be cut by S&P...OTHER NEWS: Target's (TGT) problems may benefit security firms, NY Times reports...Ventas (VTR) and Health Care REIT (HCN) held talks, dealReporter reports.
News For B;BEAM;LMCA;CHTR;TWC;PFE;VRX;ACT;MYL;NDAQ;MHFI;MCK;CAKFY;FOXA;SHLD;TGT;VTR;HCN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
February 20, 2015
09:20 EDTLMCALiberty Media initiated with an Outperform at FBN Securities
Subscribe for More Information
08:46 EDTACTActavis receives final approval for generic version of Subutex
Actavis announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex. Actavis intends to begin shipping its product shortly. Subutex is indicated for the treatment of opioid dependence. For the 12 months ending December 31, 2014, Subutex had total U.S. sales of approximately $108M, according to IMS Health data.
08:07 EDTACTActavis price target raised to $340 from $310 at Argus
Argus increased its price target on Actavis as the firm believes that the company is generating strong growth. Argus is upbeat on the company's acquisition of Allergan and keeps a Buy rating on the shares.
07:32 EDTHCNHealth Care REIT sees FY15 FFO $4.25-$4.35, consensus $4.33
Subscribe for More Information
07:31 EDTHCNHealth Care REIT reports Q4 normalized FFO $1.03, consensus $1.02
Subscribe for More Information
07:23 EDTPFEAbbVie replaces Pfizer as top global pharma pick at Jefferies
Subscribe for More Information
07:20 EDTTGTWal-Mart wage increase may pressure Target, Staples, Reuters says
Wal-Mart's (WMT) wage increase announcement will likely pressure the retail, fast-food, and restaurant sectors to potentially follow suit, reports Reuters, citing an Edward Jones analyst and the managing director of consultancy firm Strategic Resource Group. The analysts specifically named Target (TGT) and Staples (SPLS). Reference Link
07:08 EDTMYLAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
06:32 EDTBBarnes Group reports Q4 Industrial sales up 8% to $198.2M
Subscribe for More Information
06:32 EDTBBarnes Group sees FY!5 adjusted EPS $2.42-$2.57, consensus $2.49
Sees FY15 revenue growth of 3%-6%, consensus $1.34B. Sees FY15 organic revenue growth of 6%-9%. Sees FY15 operating margins to be in the range of 16%-17%. Sees FY15 CapEx $55M-$60M. Sees FY15 cash conversion to approximate 100% of net income.
06:30 EDTBBarnes Group reports Q4 adjusted EPS 62c, consensus 61c
Subscribe for More Information
February 19, 2015
18:25 EDTPFEPiper Jaffray biotech analyst to hold analyst/industry conference call
Subscribe for More Information
15:32 EDTHCNNotable companies reporting before tomorrow's open
Subscribe for More Information
14:49 EDTPFEWalgreens selected by Pfizer as one of pharmacies to dispense Ibrance
Subscribe for More Information
09:33 EDTACTActavis should be bought on weakness, says Sterne Agee
Subscribe for More Information
07:44 EDTACTActavis to sell 4.2B ordinary shares and $4.2B convertible preferred shares
Subscribe for More Information
07:40 EDTACTActavis price target raised to $352 from $300 at Canaccord
Subscribe for More Information
07:39 EDTACTActavis price target raised to $328 from $310 at Leerink
Subscribe for More Information
07:28 EDTACTActavis files automatic mixed securities shelf
Subscribe for More Information
07:12 EDTPFEWharton Health Care Club to hold a conference
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use